東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Treating urothelial bladder cancer

Soria, Francesco.

FindBook

Google Book

Amazon

博客來

Treating urothelial bladder cancer

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Treating urothelial bladder cancer/ edited by Francesco Soria, Paolo Gontero.
其他作者:	Soria, Francesco.
出版者:	Cham :Springer International Publishing : : 2018.,
面頁冊數:	viii, 133 p. :digital ;24 cm.
內容註:	Preface -- Part I: Bladder cancer diagnosis -- Imaging and bladder cancer: can we do better? -- Optical improvements in bladder cancer diagnosis: seeing better for a better management -- Enhancing the quality of transurethral resection: the importance of a complete TURB and the en-bloc resection -- Active surveillance for low risk non-muscle invasive bladder cancer -- Part II: Non-muscle invasive bladder cancer -- How good we are to predict the outcomes of non-muscle invasive bladder cancer? -- Adjuvant treatment: old and new immunotherapy in non-muscle invasive bladder cancer -- The role of new experimental conservative therapies for high risk non-muscle invasive bladder cancer. Could we trust them? -- Part III: Muscle invasive bladder cancer -- Is there still a role for radical cystectomy? -- Minimally invasive radical cystectomy and its role in the treatment of bladder cancer patients. Myth or reality? -- Neoadjuvant vs adjuvant chemotherapy: which is right? -- Radiotherapy for the treatment of muscle invasive bladder cancer -- Immunotherapy and new combinations -- Part IV: A view on the future -- The role of urologist -- The role of pathologist -- The role of medical oncologist -- The role of radiotherapist.
Contained By:	Springer eBooks
標題:	Bladder - Cancer -
電子資源:	http://dx.doi.org/10.1007/978-3-319-78559-2
ISBN:	9783319785592

Treating urothelial bladder cancer
Treating urothelial bladder cancer[electronic resource] /edited by Francesco Soria, Paolo Gontero. - Cham :Springer International Publishing :2018. - viii, 133 p. :digital ;24 cm.

Preface -- Part I: Bladder cancer diagnosis -- Imaging and bladder cancer: can we do better? -- Optical improvements in bladder cancer diagnosis: seeing better for a better management -- Enhancing the quality of transurethral resection: the importance of a complete TURB and the en-bloc resection -- Active surveillance for low risk non-muscle invasive bladder cancer -- Part II: Non-muscle invasive bladder cancer -- How good we are to predict the outcomes of non-muscle invasive bladder cancer? -- Adjuvant treatment: old and new immunotherapy in non-muscle invasive bladder cancer -- The role of new experimental conservative therapies for high risk non-muscle invasive bladder cancer. Could we trust them? -- Part III: Muscle invasive bladder cancer -- Is there still a role for radical cystectomy? -- Minimally invasive radical cystectomy and its role in the treatment of bladder cancer patients. Myth or reality? -- Neoadjuvant vs adjuvant chemotherapy: which is right? -- Radiotherapy for the treatment of muscle invasive bladder cancer -- Immunotherapy and new combinations -- Part IV: A view on the future -- The role of urologist -- The role of pathologist -- The role of medical oncologist -- The role of radiotherapist.

This book aims to bring together the current research and discussions surrounding bladder cancer management. New technologies and therapeutic agents have become increasingly effective at treating urothelial bladder cancer and have created a range of opportunities to change the ways in which the disease is treated. Chapters cover the changes in adjuvant treatment, confocal laser endomicroscopy, and the roles of oncologists, pathologists, and radiotherapists in managing bladder cancer. Treating Urothelial Bladder Cancer is particularly relevant to urologists, oncologists, and radiotherapists, but is also applicable to practitioners, geriatricians, and public health managers due to its multidisciplinary approach to bladder cancer management.

ISBN: 9783319785592

Standard No.: 10.1007/978-3-319-78559-2doiSubjects--Topical Terms:

1066930
Bladder
--Cancer

LC Class. No.: RC280.B5 / T743 2018

Dewey Class. No.: 616.9946206

Treating urothelial bladder cancer
LDR:02911nmm a2200313 a 4500 001 2152558
003 DE-He213
005 20190130152358.0
006 m d
007 cr nn 008maaau
008 190403s2018 gw s 0 eng d
020 $a 9783319785592 $q (electronic bk.)
020 $a 9783319785585 $q (paper)
024 7 $a 10.1007/978-3-319-78559-2 $2 doi
035 $a 978-3-319-78559-2
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.B5 $b T743 2018
072 7 $a MJS $2 bicssc
072 7 $a MED088000 $2 bisacsh
082 0 4 $a 616.9946206 $2 23
090 $a RC280.B5 $b T784 2018
245 0 0 $a Treating urothelial bladder cancer $h [electronic resource] / $c edited by Francesco Soria, Paolo Gontero.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2018.
300 $a viii, 133 p. : $b digital ; $c 24 cm.
505 0 $a Preface -- Part I: Bladder cancer diagnosis -- Imaging and bladder cancer: can we do better? -- Optical improvements in bladder cancer diagnosis: seeing better for a better management -- Enhancing the quality of transurethral resection: the importance of a complete TURB and the en-bloc resection -- Active surveillance for low risk non-muscle invasive bladder cancer -- Part II: Non-muscle invasive bladder cancer -- How good we are to predict the outcomes of non-muscle invasive bladder cancer? -- Adjuvant treatment: old and new immunotherapy in non-muscle invasive bladder cancer -- The role of new experimental conservative therapies for high risk non-muscle invasive bladder cancer. Could we trust them? -- Part III: Muscle invasive bladder cancer -- Is there still a role for radical cystectomy? -- Minimally invasive radical cystectomy and its role in the treatment of bladder cancer patients. Myth or reality? -- Neoadjuvant vs adjuvant chemotherapy: which is right? -- Radiotherapy for the treatment of muscle invasive bladder cancer -- Immunotherapy and new combinations -- Part IV: A view on the future -- The role of urologist -- The role of pathologist -- The role of medical oncologist -- The role of radiotherapist.
520 $a This book aims to bring together the current research and discussions surrounding bladder cancer management. New technologies and therapeutic agents have become increasingly effective at treating urothelial bladder cancer and have created a range of opportunities to change the ways in which the disease is treated. Chapters cover the changes in adjuvant treatment, confocal laser endomicroscopy, and the roles of oncologists, pathologists, and radiotherapists in managing bladder cancer. Treating Urothelial Bladder Cancer is particularly relevant to urologists, oncologists, and radiotherapists, but is also applicable to practitioners, geriatricians, and public health managers due to its multidisciplinary approach to bladder cancer management.
650 0 $a Bladder $x Cancer $x Treatment. $3 1066930
650 1 4 $a Medicine & Public Health. $3 890906
650 2 4 $a Urology. $3 636586
650 2 4 $a Oncology. $3 751006
650 2 4 $a Radiotherapy. $3 862372
700 1 $a Soria, Francesco. $3 3338981
700 1 $a Gontero, Paolo. $3 3338982
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-78559-2
950 $a Medicine (Springer-11650)